Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(1-((6-fluoro-2-naphthyl)methyl)pyrrolidin-3-yl)-2-(1-((3-methyl-1-oxidopyridin-2-yl)carbonyl)piperidin-4-ylidene)acetamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(1-((6-fluoro-2-naphthyl)methyl)pyrrolidin-3-yl)-2-(1-((3-methyl-1-oxidopyridin-2-yl)carbonyl)piperidin-4-ylidene)acetamide
Unique ID
C508080
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C508080
Entry Term(s)
YM 344031
YM-344031
YM344031
Registry Numbers
0
Heading Mapped to
*Amides
*Pyridinium Compounds
Frequency
3
Note
inhibits binding of eotaxin-1 and RANTES to CCR-3 expressing cells; may have use as an anti-asthma agent; structure in first source
Source
Biochem Biophys Res Commun 2006 Jan 27;339(4):1217-23
Date of Entry
2006/02/22
Revision Date
2006/02/22
N-(1-((6-fluoro-2-naphthyl)methyl)pyrrolidin-3-yl)-2-(1-((3-methyl-1-oxidopyridin-2-yl)carbonyl)piperidin-4-ylidene)acetamide Preferred
YM 344031 Narrower
page delivered in 0.005s